Join Biologics at the 2026 Informa Connect Access USA Rare Disease Summit
March 17-19, 2026 | Booth #328
Biologics by McKesson specialty pharmacy is proud to be a sponsor of the 2026 Informa Connect Access USA Rare Disease Summit, a leading event bringing together key stakeholders to advance rare disease access, innovation, and patient impact.
Join us at booth #328 to discuss how Biologics by McKesson can be the right partner to support your rare disease therapy across access, patient services, and commercialization. See below for more information and we’ll see you at Access USA!
Visit us at booth #328 or join our expert session – details below.
Hear from our experts!
Pioneering Payer Partnerships: Crafting Value Stories That Resonate with Key Stakeholders
Tuesday, March 17, 2026 | 4-4:30 p.m. ET
This panel will explore how to effectively communicate value to payers and support sustainable access strategies for rare disease therapies. Panelists will break down the essentials of early payer engagement, evidence planning, and demonstrating impact in rare and ultra‑rare diseases.
Let's connect at the Rare Disease Summit. Fill out the form below to schedule time with our experts.
Stephanie Patten
VP, Rare Disease and Advanced Therapies
George Pachal
VP, Business Development
Ryan Hampton
VP, Industry Relations and Implementation
Ben Matherne
VP, Business Insights and Special Projects
Chris Alfaro
Sr. Manager, Strategic Accounts
Evan Thomes
Sr. Associate, Business Development
Tony Braun
Sr. Director, Contract Administration